UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Number of items: 18.


Barkhof, F; Van Waesberghe, J-HTM; Polman, CH; Filippi, M; Yousry, T; Miller, DH; Thompson, AJ; (2001) T hypointense lesions in secondary progressive multiple sclerosis: Effect of interferon beta-1b treatment. Brain , 124 (7) 1396 - 1402.

Camp, SJ; Thompson, AJ; Langdon, DW; (2001) A new test of memory for multiple sclerosis I: Format development and stimuli design. MULT SCLER , 7 (4) 255 - 262.

Freeman, JA; Hobart, JC; Thompson, AJ; (2001) Does adding MS-specific items to a generic measure (the SF-36) improve measurement? NEUROLOGY , 57 (1) 68 - 74.

Freeman, JA; Thompson, AJ; Fitzpatrick, R; Hutchinson, M; Miltenburger, C; Beckmann, K; Dahlke, F; (2001) Interferon-beta 1b in the treatment of secondary progressive MS - Impact on quality of life. NEUROLOGY , 57 (10) 1870 - 1875.

Freeman, JA; Thompson, AJ; Freeman, JA; (2001) Building an evidence base for multiple sclerosis management: support for physiotherapy. J NEUROL NEUROSUR PS , 70 (2) 147 - 148.

Hobart, J; Freeman, J; Lamping, D; Fitzpatrick, R; Thompson, A; (2001) The SF-36 in multiple sclerosis: why basic assumptions must be tested. J NEUROL NEUROSUR PS , 71 (3) 363 - 370.

Hobart, J; Lamping, D; Fitzpatrick, R; Riazi, A; Thompson, A; (2001) The Multiple Sclerosis Impact Scale (MSIS-29) - A new patient-based outcome measure. BRAIN , 124 962 - 973.

Hobart, JC; Thompson, AJ; (2001) The five item Barthel index. J NEUROL NEUROSUR PS , 71 (2) 225 - 230.

Jarrett, L; Leary, SM; Porter, B; Richardson, D; Rosso, T; Powell, M; Thompson, AJ; (2001) Managing spasticity in people with multiple sclerosis: a goal-oriented approach to intrathecal baclofen therapy. International Journal of MS Care , 3 (4)

Kappos, L; Polman, C; Pozzilli, C; Thompson, A; Beckmann, K; Dahlke, F; European Study Grp Beta-1b Seconda, ; (2001) Final analysis of the European multicenter trial on IFN beta-1b in secondary-progressive MS. NEUROLOGY , 57 (11) 1969 - 1975.

Kristoferitsch, W; Seeldrayers, P; Kyriallis, K; Brochet, B; Confavreux, C; Clanet, M; Cesaro, P; (2001) Double-blind randomized multicenter dose-comparison study of interferon-beta-1a (AVONEX): rationale, design and baseline data. MULTIPLE SCLEROSIS , 7 (3) 179 - 183.

McDonald, WI; Compston, A; Edan, G; Goodkin, D; Hartung, HP; Lublin, FD; McFarland, HF; (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. ANN NEUROL , 50 (1) 121 - 127.

Thompson, AJ; (2001) Symptomatic management and rehabilitation in multiple sclerosis. J NEUROL NEUROSUR PS , 71 II22 - II27.

Willison, HJ; O'Leary, CP; Veitch, J; Blumhardt, LD; Busby, M; Donaghy, M; Fuhr, P; (2001) The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. BRAIN , 124 1968 - 1977.


Polman, CH; Thompson, AJ; Murray, TJ; McDonald, WI; (2001) Multiple sclerosis: the guide to treatment and management. (5th ed.). Demos: New York.

Book chapter

Hobart, JC; Thompson, AJ; (2001) Assessment measures and clinical scales. In: Guiloff, RJ, (ed.) Clinical trials in neurology. (17 - 28). Springer Verlag: London.

Thompson, AJ; (2001) Drug treatment of neurological disability. In: Edwards, S, (ed.) Neurological physiotherapy: a problem solving approach. (155 - 168). Churchill Livingstone: London.

Thompson, AJ; (2001) Symptomotic treatment and rehabilitation. In: Polman, CH and Thompson, AJ and Murray, TJ and McDonald, WI, (eds.) Multiple sclerosis: the guide to treatment and management. (43 - 78). Demos: New York.

This list was generated on Sun Aug 16 07:25:52 2015 BST.